Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (NYSE: ELV) generates a steady stream of news as a major participant in the direct health and medical insurance carriers industry. Company updates frequently focus on financial performance, member experience initiatives, digital tools, and community health programs. Investors and observers following ELV news can see how Elevance Health communicates its strategy as a lifetime, trusted health partner serving over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.
News coverage often includes earnings results and guidance, such as quarterly financial releases that detail segment performance for Health Benefits and Carelon, membership trends across commercial, Medicare, Medicaid, and Federal Employee Program lines, and commentary on benefit expense ratios and operating metrics. The company also issues announcements about upcoming conference calls and webcasts where management reviews results and outlook with investors.
Another key theme in Elevance Health news is the evolution of the healthcare consumer experience. Articles describe AI-enabled digital solutions, including the Virtual Assistant available through the Sydney Health app, which helps members understand benefits, compare costs, and find in-network providers. The company also highlights care management programs, concierge-style support for serious illnesses, and models such as “My Health Advocate” in affiliated Medicare plans.
Elevance Health news frequently covers whole-health and community initiatives. Examples include Food as Medicine partnerships with the National Association of Community Health Centers, school-based fitness facility upgrades, and expanded access to doula care and social supports in certain Medicare Advantage and Medicaid plans. Governance developments, such as the appointment of independent directors to the board and related committee assignments, are also reported through press releases and SEC-linked announcements.
By reviewing the ELV news feed on this page, readers can follow financial disclosures, strategic initiatives, digital and clinical innovations, and community-focused programs that shape Elevance Health’s role in the health benefits and healthcare services landscape.
Elevance Health (NYSE: ELV) has earned full three-year accreditation for health equity from the National Committee for Quality Assurance (NCQA) for 21 of its affiliated Medicaid plans. This accreditation highlights the company's commitment to enhancing health equity and addressing the needs of historically marginalized communities. Currently, 93% of Elevance Health's Medicaid members are enrolled in accredited plans, representing a significant achievement in the industry. The company aims to innovate and improve care for diverse populations across the nation.
Elevance Health has partnered with Impact Fitness Foundation to enhance the fitness resources at Herron-Riverside High School in
The upgraded facility, unveiled on
Elevance Health announces its agreement to acquire BioPlus, a specialty pharmacy under CarepathRx, enhancing its specialty drug solutions for complex conditions like cancer and autoimmune diseases. This acquisition supports Elevance's whole-health strategy, aiming to improve access and reliability for clients. Post-acquisition, BioPlus will operate under IngenioRx, Elevance's pharmacy benefit manager. The deal is set to close in the first half of 2023, with no expected material impact on adjusted earnings per share this year.
Elevance Health (NYSE: ELV) will present at the 4th Annual Wolfe Research Healthcare Conference in New York City on November 16 at 10:00 a.m. EST. Stakeholders can access the live webcast by visiting Elevance Health’s website. A replay will be available for 90 days post-presentation. Elevance Health is dedicated to enhancing healthcare access for over 119 million individuals through its comprehensive portfolio of medical, digital, and behavioral health solutions.
The recent study commissioned by Elevance Health reveals that 94% of Americans who used virtual primary care are satisfied, with 79% feeling empowered about their health. Conducted by The Harris Poll, the survey of over 5,000 adults shows that convenience and accessibility are key attractions to virtual care. While 48% are familiar with the term, 73% find it appealing. Many Americans, especially those with chronic conditions, see it as a way to enhance healthcare access. The study confirms a significant rise in telehealth usage, nearly 20 times pre-pandemic levels.
Elevance Health (NYSE: ELV) will present at the 31st Annual Credit Suisse Healthcare Conference on November 9, at 11:35 a.m. PST in Rancho Palos Verdes, California. Interested individuals can access the live webcast via www.elevancehealth.com. A replay will be available for 90 days after the presentation. Elevance Health serves over 119 million people with a range of healthcare solutions, dedicated to improving health outcomes and supporting communities.
The Board of Directors of Elevance Health (NYSE: ELV) announced the appointment of Deanna Strable to the Board. With over 30 years in financial services, Strable is currently CFO of Principal Financial Group, responsible for financial integrity and growth. Her experience includes leading the U.S. Insurance Solutions division. Strable's appointment brings the board's female and diverse director representation to over 70%. Elizabeth Tallett, Board Chair, highlighted her proven expertise in the insurance sector and commitment to diversity.
Elevance Health reported strong third quarter 2022 results with a GAAP net income of $6.68 per share, adjusted net income at $7.53 per share, and operating revenue of $39.6 billion, up 11.5% year-over-year. Medical enrollment increased by 2.2 million to 47.3 million members. The company also declared a fourth quarter dividend of $1.28 per share. With a projected full-year GAAP net income exceeding $25.33 per share, Elevance demonstrates robust growth driven by strategic operations and increasing membership.
Elevance Health announced its affiliated health plans will offer $0 premium Medicare Advantage plans targeting nearly 33 million Medicare-eligible individuals. With inflation impacting costs, three-quarters of their plans for 2023 feature zero premiums and no co-pays for primary care visits. A new prepaid benefits card simplifies access to various benefits. Additionally, eligible consumers can receive grocery card benefits and access to dietitians. The plans will expand to serve 2.1 million new Medicare-eligible consumers across 145 counties, bolstering Elevance Health's presence in the Medicare market.
Elevance Health has announced that its affiliated Medicare Advantage plans received an overall 4 out of 5 Star rating from the Centers for Medicare & Medicaid Services (CMS) for 2023. Notably, 64% of beneficiaries will enroll in plans rated 4 Stars or higher. Some plans, including HealthSun Health Plans and Optimum Healthcare, achieved the maximum 5 Star rating for multiple years. This success is attributed to improved consumer experiences and a focus on digital innovations aimed at enhancing health outcomes.